Efficacy of cetuximab-based second-line therapy in patients with metastatic head and neck squamous cell carcinoma (HNSCC) which progressed on gefitinib-based first-line therapyJennifer Mosley, Douglas R. Adkins, T. Rachocki et al.|Journal of Clinical Oncology|2008Cited by 0